# Technical Product Requirements Specification Template
## Healthcare AI Solution

> **TEMPLATE DIRECTIVE:** 
> This document serves as the standardized Technical Product Requirements Specification framework for Healthcare AI Solutions. To ensure cross-functional alignment, regulatory compliance, and architectural consistency, **authors must adhere to the established section and subsection hierarchy.** 
> *Instructions:* Populate the designated fields with project-specific data. Bracketed text `*[...]*` and tables marked as "Example" denote instructional placeholders and structural references; these must be overwritten or excised in the finalized specification.


### Document Metadata
*   **Document ID:** 
*   **Author / Owner:** 
*   **Target Release:** 
*   **Compliance Baseline:** GDPR / CDSCO / DPDP
*   **Security Review Status:** [Pending / Approved]
*   **Document Version:** 
*   **Classification:** Confidential / Public / Internal 

---

## 1. Executive Summary
*[Provide a high-level distillation of the product/Feature, clinical/operational value proposition, and intended AI output.]*

---

## 2. Problem Statement & Impact Opportunity
### Example:    
### 2.1 Clinical & Workflow Pain Points
*[Detail diagnostic delays, data silos, transcription bottlenecks, or clinician burnout factors.]*

### 2.2 The AI Hypotheses & Target Intervention
*[State clearly where the AI sits in the decision-making loop: diagnostic aid, autonomous screener, or post-hoc auditor.]*

### 2.3 Proposed Risk Tier
*[ E.g., if AI is used for diagnostic purposes, it is high risk. If AI is used for operational purposes, it is low risk.]*
*[E.g., If used in doctor-patient interaction, it is high risk, if used for offline, analytics-only  data processing, it is low risk]*

---

## 3. Success Metrics & Key Performance Indicators (KPIs)
### Example:

| Dimension | Success Metric / Evaluator | Target Baseline Threshold |
| :--- | :--- | :--- |
| **Productivity Gains** | Reduced Turnaround Time (TAT), Increased efficiency,  | [e.g., 30% reduction in TAT] |
| **Accuracy** | Sensitivity, Specificity, F1-Score, AUC-ROC on local validation slices. | [e.g., Sensitivity ≥ 94%] |
| **Operational Trust** | AI acceptance rate (percentage of AI suggestions kept intact by clinician). | [e.g., ≥ 85% acceptance] |

---

## 4. Actors, Personas & Responsibilities Matrix
### Example: 

| Actor / Persona | Core Responsibilities | PHI / PII Data Access Level |
| :--- | :--- | :--- |
| **Clinical End-User**<br><small>(e.g., Pathologist, Radiologist)</small> | Validates AI inference outputs; flags false positives/negatives; signs off on final clinical findings. | **Full Access:** Explicitly tied to assigned patients within active clinical workflows. |
| **Hospital IT & PACS/EMR Admin** | Manages HL7/FHIR interfaces, DICOM routing rules, network tunnels, and sidecar node health. | **Infrastructure Access Only:** System-level management; zero direct visualization of raw clinical PHI. |
| **Data Scientist / ML Engineer** | Monitors data/concept drift, tracks inference errors, and coordinates offline model retraining. | **Zero/Anonymized Access:** De-identified/pseudonymized research data slices only. No direct raw PHI access. |
| **Hospital Compliance & Privacy Officer** | Conducts routine access audits, reviews BAA/DPA boundaries, signs off on data processing registries. | **Audit Access:** Permitted to view immutable transaction logs, access reports, and consent registries. |

---

## 5. Prerequisites & System Dependencies

### 5.1 Legal & Compliance Prerequisites
*   **Global/Regional Data Privacy & Security Compliance**
    * [Compliance frameworks that govern data privacy, consent, data locality, data sharing, and PHI handling in target regions. Examples: GDPR, DPDP Act]

*   **Medical Device Standards Compliance**
    * [Device hardware (e.g. sensors, scanners, cameras, microphones, etc.), firmware and software, etc. compliance to Medical Device Standards and Regulations]

### 5.2 Functional Prerequisites
*   **Workflow Changes or Assumptions**
    *   Current workflow 
    *   Proposed Workflow 
*   **Low-Fidelity (Lo-Fi) Mockups for User Review**
    *   *[Link to or embed structural wireframes illustrating the proposed clinical workflow, screen layouts, and AI interaction points for early clinical validation before engineering begins.]*
*   **Data Formats and Data Sources**
    *   Data Model, schema definitions
        *   [X] 
        *   [Y] 
        *   [Z] 
    *   Datasources 
        *   Structured Data
        *   Unstructured Data 
        *   Semi-structured Data

### 5.3 Technical Infrastructure Prerequisites
*[List the foundational environments, hardware, and toolchains required before AI engineering can commence.]*
*[Objective is to identify dependencies, bottlenecks and budget constraints and work towards mitigating them.]*

*   **Compute & Accelerators:** 
    *   [Specify required hardware (e.g., GPUs, TPUs) and memory footprints for model training, fine-tuning, and inference.]
    *   [Provisioned development clusters or cloud quota allocations for data science teams.]

*   **Data & Storage Infrastructure:** 
    *   [Data Lake/Warehouse provisioning for storing raw and processed training datasets.]
    *   [Vector Database provisioning (if utilizing Retrieval-Augmented Generation / RAG).]
    *   [Secure, isolated staging zones for handling and scrubbing de-identified clinical data.]

*   **MLOps & Toolchain Access:**
    *   [Provisioned access to Experiment Tracking and Model Registries (e.g., MLflow, Weights & Biases).]
    *   [Container registries and CI/CD pipelines configured for ML artifact management.]

*   **Network & Integration Pathways:** 
    *   [Secure Site-to-Site VPNs or dedicated interconnects to hospital systems (e.g., PACS, EMR).]
    *   [Approved firewall egress rules or Private Links to third-party foundational model APIs (e.g., OpenAI, Azure) to enable agentic workflows.]

### 5.4 Information Security Review
*   [Security Review Checklist]

---

## 6. Functional Requirements or Core Feature Set
*[Functional Requirements at use case level abstraction. Clearly delineate boundaries for the MVP.]*

### 6.1 In Scope (MVP)
*[Detail the functional requirements and use cases that are strictly required for the initial release.]*
#### Example: 

| Use Case | Inputs | Outputs | Decision Trigger |
| :--- | :--- | :--- | :--- |
|UseCase 1| Input 1 | Output 1| Pass If condition met , Acceptable If condition met, Reject If condition not met | 
|UseCase 2| Input 2 | Output 2| Pass If condition met , Acceptable If condition met, Reject If condition not met | 
|UseCase 3| Input 3 | Output 3| Pass If condition met , Acceptable If condition met, Reject If condition not met |

### 6.2 Out of Scope
*[Explicitly list features, use cases, or integrations that will NOT be supported. This helps manage expectations and prevents scope creep.]*

### 6.3 Deferred for Future Phases (Post-MVP)
*[List items intentionally excluded from the MVP that are planned for subsequent iterations. (High-level themes can also be mapped in Section 14).]*

---

## 7. System Architecture
*[Component Diagram showing interactions within and external systems]*

### 7.1 Software Composition Matrix
*[List of key Open source/Commercial software used including AI/ML artifacts.]*

### 7.2 Inference Pipelines
*[Specify requirements for automated image/text ingestion, pre-processing, model inference execution, payload extraction, and return loops.]*

### 7.3 Multi-Model Interface & Orchestration
*[Detail requirements for supporting multiple AI models, including model routing, ensemble logic, fallback mechanisms, and standardized API contracts.]*

### 7.4 Model Versioning & Execution Context
*[Outline requirements for managing model artifacts, version control, A/B testing infrastructure, and execution context boundaries.]*

### 7.5 Agentic AI Architecture & Tooling
*[Define requirements for autonomous agent behavior, including task decomposition, tool/API access constraints, multi-agent orchestration, state/memory management (short-term vs. long-term), and human-in-the-loop (HITL) approval gates for critical actions.]*

---

## 8. Data Privacy, Security & PHI/PII Handling
> ⚠️ **STRICT GUARDRAIL:** Zero unencrypted PHI/PII may ever traverse external network perimeters. All data pipelines must actively separate identity attributes from analytical data payloads before executing off-premise inference loops.

### 8.1 De-identification & Pseudonymization 
#### Example
*   **In-Flight PII Striping:** *[Specify the mechanisms and rule engines used to automatically scrub direct patient identifiers (e.g., Names, MRNs, DOBs) from clinical payloads (HL7/FHIR payloads, DICOM headers, or unstructured te xt) before data is transmitted to the AI inference engine.]*
*   **Secure Token Vaulting (Re-identification):** *[Detail the architecture for pseudonymization. Explain how stripped identities are replaced with opaque session tokens and stored in a local, secure mapping vault. This ensures AI inferences can be accurately re-linked to the correct patient record upon return, without ever exposing the identity to the underlying model.]*

### 8.2 Technical Controls Matrix
 
| Control Category | Technical Specification Requirements |
| :--- | :--- |
| **Encryption Architecture** | AES-256 for all persistent storage volumes. TLS 1.3 enforced for data-in-transit, rejecting degraded ciphers. |
| **Access Control (RBAC)** | Attribute-Based and Role-Based Access Controls verifying active clinician credentials against active patient lists. |
| **Immutable Auditing** | Log generation tracking all actions involving PHI access, configuration adjustments, and user override actions. Logs must be piped to a tamper-proof write-once-read-many (WORM) storage system. |

### 8.3 Data Retention & Lifecycle Management
*[Specify the time-to-live (TTL) for raw clinical payloads, post-inference cleanup processes, and compliance with data archiving regulations (e.g., automated deletion policies).]*

### 8.4 Secondary Use & Model Training Data
*[Detail conditions under which user data may be anonymized and used for continuous model learning, explicit consent frameworks, opt-out mechanisms, and strict separation of training datasets from live clinical systems.]*

---

## 9. Multi-Site Onboarding & Tenant Provisioning Workflow

### 9.1 **Compliance & Local Clearance Process**
*[Define the steps for executing Data Acquisition, Data Processing Agreements (DPAs), and securing local data privacy sign-offs per hospital site prior to any data transmission.]*

### 9.2 **Network & Edge Infrastructure Provisioning**
*[Detail the technical onboarding of a new site, including establishing secure Site-to-Site VPNs, deploying local edge-computing nodes (e.g., PHI-scrubbing sidecars or local DICOM routers), and configuring routing to the central cloud inference engine.]*

### 9.3 **Identity Federation & Access Mapping**
*[Specify how the AI platform integrates with the local hospital's existing Identity Provider (IdP) or Active Directory via SAML/OIDC to enable Single Sign-On (SSO) and seamlessly map local clinician roles to platform permissions.]*

### 9.4 **Clinical User Training & Change Management**
*[Outline the adoption program for new hospital sites, including initial champion-user training, distribution of 'Explainable AI' usage manuals, and dedicated go-live support structures.]*

---

## 10. Release Management & Rollout Strategy

### 10.1 AI & App Release Cadence (CI/CD/CT)
*[Detail dual-track release pipelines: one for deterministic software (e.g., UI, APIs) and one for continuous training/probabilistic AI components (e.g., model weight updates, prompt tuning). Specify automation for evaluating AI regressions before deployment.]*

### 10.2 Product Upgrades, Prompt Hotfixes & Rollbacks
*[Outline processes for resolving traditional software bugs vs. AI-specific anomalies (e.g., hallucinations, context-length truncation). Detail how prompt-level hotfixes or instant model rollbacks are executed without disrupting clinical workflows.]*

### 10.3 AI Issue Tracking, Triage & Annotation
*[Specify workflows for capturing user-reported AI inaccuracies. Include the process for routing complex AI issues to subject-matter experts (SMEs) or clinical annotators for review before integrating into the fine-tuning backlog.]*

### 10.4 Phased Deployment Strategy
#### Example: 
#### Phase 1: Shadow / Silent Deployment Mode (Duration: [X] Weeks)
*   **Objective:** Validate system plumbing, verify end-to-end integration latencies, and look for runtime pipeline exceptions.
*   **Behavior:** The production data feeds actively replicate into the AI module. Inferences execute normally, but results are strictly hidden from clinicians. Zero clinical decisions are influenced.

#### Phase 2: Targeted Champion Pilot (Duration: [X] Weeks)
*   **Objective:** Solicit real-world interface feedback and establish user-experience baseline metrics.
*   **Behavior:** AI results are visible exclusively to a designated group of "champion" clinicians. Outputs require physical confirmation or correction before updating active diagnostic queues.

#### Phase 3: Phased Clinical Expansion (Staged Ramp: 10% → 50% → 100%)
*   **Objective:** Scale platform concurrency stress while ensuring system stability across all clinical sub-departments.
*   **Behavior:** Broad rollout to entire clinical teams, managed through gradual user traffic shifts or individual hospital location activations.

---

## 11. Operational Requirements & MLOps Lifecycle
### 11.1 High Availability & Clinical Continuity
*   **Fail-Safe Modes:** In the event of an AI inference crash, system design must guarantee immediate, transparent failback to standard manual clinical workflows. The integration layer must never lock clinical screens.
*   **Disaster Recovery:** Recovery Time Objective (RTO) of [e.g., ≤ 15 minutes] for high-urgency clinical environments; Recovery Point Objective (RPO) of [e.g., ≤ 1 minute] for metadata consistency.

### 11.2 Distributed Telemetry & Observability
*   **End-to-End Tracing:** 
    *   **Inference & Prompt Logging:** Capture the full lineage of prompts, token consumption, model configurations (e.g., temperature), and raw model responses to ensure reproducibility.
    *   **Agentic Execution Tracing:** Log multi-step reasoning paths (Chain-of-Thought), tool/API invocations made by the agent, intermediate action outcomes, and memory/state transitions.
    *   **Distributed Context Propagation:** Utilize standards like OpenTelemetry or specialized AI observability tools (e.g., LangSmith, Arize) to trace requests seamlessly from the user interface, through routing microservices, down to the underlying models and external retrieval pipelines (RAG).

### 11.3 Model & Data Drift Handling
*   **Monitoring Metrics:** [Define statistical tests or metrics used to detect data distribution shifts or model performance degradation.]
*   **Alerting & Mitigation:** [Automated alerts trigger to MLOps when data shift impacts overall predictive accuracy. Outline mitigation strategies, such as fallback mechanisms or manual overrides.]

### 11.4 Feedback Capturing for AI Outputs
*   **User Feedback Loops:** [Specify mechanisms for end-users to accept, reject, or correct AI predictions (e.g., UI elements for flagging false positives/negatives).]
*   **Data Provenance:** [Ensure all captured feedback is securely stored and immutably linked to the original inference payload and specific model version.]

### 11.5 Model Fine-Tuning & Re-Training Criteria
*   **Re-Training Triggers:** [Define explicit thresholds that necessitate model re-training, such as a drop in accuracy below a baseline, or a specific volume of negative user feedback.]
*   **Fine-Tuning Pipelines:** [Outline the process for curating captured feedback and integrating it into continuous learning workflows or fine-tuning pipelines.]
*   **Deployment Gates:** [Specify validation requirements (e.g., shadow testing, offline evaluation) that updated models must pass before replacing the active production model.]

### 11.6 Token Metering & Cost Management
*   **Usage Tracking & Metering:** [Define mechanisms to track prompt and completion token consumption at the tenant, department, or individual user level for billing and capacity planning.]
*   **Quota Enforcement:** [Specify soft and hard token limits (e.g., daily/monthly allocations) to prevent billing overruns or API abuse.]
*   **Overage Fallbacks & Graceful Degradation:** [Outline system behavior when token limits are exceeded (e.g., dynamically routing traffic to a smaller, more cost-effective fallback model, shedding non-critical context window history, or returning a user-facing quota error without breaking the app flow).]

---

## 12. Regulatory, Compliance & AI Safety
*[Outline clinical safety profiles, expected retrospective performance dossiers, requirements for Explainable AI dashboards, and software-as-a-medical-device (SaMD) classifications.]*

### 12.1 AI Bias & Fairness Validation
*[At a high level, ensure the model performs equitably across different demographic groups. Define expectations for evaluating and mitigating bias in training data.]*

### 12.2 Safety Guardrails & Hallucination Prevention
*[Specify high-level system safeguards (e.g., secondary validation models, deterministic rule engines) designed to intercept and block clinically unsafe hallucinations or out-of-bounds outputs.]*

### 12.3 Explainability & Transparency (XAI)
*[Define the requirement for making AI decisions transparent to end-users (e.g., providing verifiable source citations, confidence scores, or visual heatmaps alongside predictions).]*

---

## 13. Non-Functional Performance Thresholds
*[Outline performance, load and availability thresholds so that it can help in capacity planning, cost estimation and SLA definition]*

### 13.1 Estimated Load & Scale Characteristics
#### Example:
*   **Daily Active Users (DAU):** [Expected DAU]
*   **Concurrent Users (CCU):** [Expected peak CCU]
*   **Requests Per Second (RPS):** [Expected average and peak RPS]
*   **Data Volume / Throughput:** [Expected data ingested per day/hour]

### 13.2 Latency & Availability
#### Example:
*   **End-to-End Response Latency:** The total round-trip time from user query to final AI output (including any multi-step agentic reasoning or data retrieval) must complete within an acceptable threshold [e.g., ≤ 5 seconds].
*   **Perceived Responsiveness:** For generative features, initial system feedback or streaming onset should be near-instantaneous to maintain user engagement [e.g., ≤ 500ms].
*   **AI Infrastructure Availability:** Core AI models and third-party APIs must meet high uptime SLAs [e.g., 99.9%].
*   **System Resiliency & Graceful Degradation:** The platform must gracefully handle upstream AI model outages or rate limits by seamlessly routing to fallback models without breaking the clinical workflow.
*   **Overall Platform Availability:** Continuous target operation rate of [e.g., 99.95%] over any calendar month period.

---

## 14. Product Roadmap & Future Scope
*[Differentiate MVP capabilities from subsequent iterations, detailing features like multi-modal diagnostic fusion or federated training architectures across hospital systems.]*
